Interstitial pneumonitis associated with trastuzumab emtansine
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218813716
Abstract: Trastuzumab emtansine is an antibody–drug conjugate that is effective in human epidermal growth factor receptor-2 expressing advanced breast cancer. Trastuzumab emtansine is generally well tolerated and grade 3–4 toxicities are rare. Pulmonary complications were rarely… read more here.
Keywords: pneumonitis associated; trastuzumab emtansine; associated trastuzumab; interstitial pneumonitis ... See more keywords